RU99114859A - NEW ALPHA SUB-UNIT BETA 2-HUMAN INTEGRINE - Google Patents

NEW ALPHA SUB-UNIT BETA 2-HUMAN INTEGRINE

Info

Publication number
RU99114859A
RU99114859A RU99114859/13A RU99114859A RU99114859A RU 99114859 A RU99114859 A RU 99114859A RU 99114859/13 A RU99114859/13 A RU 99114859/13A RU 99114859 A RU99114859 A RU 99114859A RU 99114859 A RU99114859 A RU 99114859A
Authority
RU
Russia
Prior art keywords
binding
vcam
binding partner
immobilized
labeled
Prior art date
Application number
RU99114859/13A
Other languages
Russian (ru)
Other versions
RU2215006C2 (en
Inventor
Уильям М. Гэллатин
Дер Вирен Моника Вэн
Original Assignee
Айкос Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/943,363 external-priority patent/US5837478A/en
Application filed by Айкос Корпорейшн filed Critical Айкос Корпорейшн
Publication of RU99114859A publication Critical patent/RU99114859A/en
Application granted granted Critical
Publication of RU2215006C2 publication Critical patent/RU2215006C2/en

Links

Claims (4)

1. Способ идентификации модулятора связывания между αd и VCAM-1, включающий в себя
a) контактирование αd и VCAM-1 в присутствии и в отсутствии предполагаемого модуляторного соединения;
b) детектирование связывания между αd и VCAM-1 и
c) идентификацию предполагаемого модуляторного соединения в связи с уменьшенным или увеличенным связыванием между αd и VCAM-1 в присутствии предполагаемого модулятора в сравнении со связыванием в отсутствие предполагаемого модулятора.
1. A method for identifying a binding modulator between α d and VCAM-1, including
a) contacting α d and VCAM-1 in the presence and absence of the intended modulator compound;
b) detecting binding between α d and VCAM-1 and
c) the identification of the putative modulator compound in connection with reduced or increased binding between α d and VCAM-1 in the presence of the putative modulator compared to the binding in the absence of the putative modulator.
2. Способ по п. 1, отличающийся тем, что его осуществляют в клетке-хозяине, содержащей растворимый αd и растворимый VCAM-1, а уменьшенное или увеличенное связывание определяют количественно посредством измерения зависимого от связывания фенотипического изменения в клетке-хозяине, возникающего вследствие изменения в экспрессии продукта репортерного гена.2. The method according to p. 1, characterized in that it is carried out in a host cell containing soluble α d and soluble VCAM-1, and reduced or increased binding is quantified by measuring the binding-dependent phenotypic change in the host cell resulting from changes in expression of the reporter gene product. 3. Способ идентификации соединения, модулирующего связывание между αd и VCAM-1, включающий в себя
a) иммобилизацию αd или его фрагмента или VCAM-1 или его фрагмента на твердом носителе;
b) мечение неиммобилизованного партнера связывания детектируемым агентом;
c) контактирование указанного иммобилизованного партнера связывания с указанным меченым партнером связывания в присутствии и в отсутствии предполагаемого модуляторного соединения, способного специфически реагировать с αd или VCAM-1;
d) детектирование связывания между указанным иммобилизованным партнером связывания и указанным меченым партнером связывания и
е) идентификацию модулирующих соединений как соединений, влияющих на связывание между указанным иммобилизованным партнером связывания и указанным меченым партнером связывания.
3. A method for identifying a compound that modulates the binding between α d and VCAM-1, including
a) the immobilization of α d or its fragment or VCAM-1 or its fragment on a solid carrier;
b) labeling the non-immobilized binding partner with a detectable agent;
c) contacting said immobilized binding partner with said labeled binding partner in the presence and in the absence of a putative modulator compound capable of specifically reacting with α d or VCAM-1;
d) detecting binding between said immobilized binding partner and said labeled binding partner; and
e) the identification of modulating compounds as compounds affecting the binding between the specified immobilized binding partner and the specified labeled binding partner.
4. Способ по п. 3, отличающийся тем, что αd или VCAM-1 иммобилизуют на твердом носителе, покрытом или пропитанном флуоресцентным агентом, указанный неиммобилизованный партнер связывания метят соединением, способным возбуждать указанный флуоресцентный агент, и взаимодействие αd с партнером связывания αd детектируют по эмиссии света из указанного флуоресцентного агента.4. The method according to p. 3, characterized in that α d or VCAM-1 is immobilized on a solid carrier coated or impregnated with a fluorescent agent, said non-immobilized binding partner is labeled with a compound capable of exciting said fluorescent agent, and the interaction of α d with α binding partner d detect by light emission from the specified fluorescent agent.
RU99114859/13A 1997-10-03 1998-10-02 METHOD FOR IDENTIFICATION OF BINDING MODULATING AGENT BETWEEN POLYPEPTIDE-αd AND VCAM-1 (VARIANTS) RU2215006C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/943,363 1997-10-03
US08/943,363 US5837478A (en) 1993-12-23 1997-10-03 Method of identifying modulators of binding between and VCAM-1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2003121295/13A Division RU2003121295A (en) 1997-10-03 2003-07-14 NEW HUMAN BETA2-INTEGRINE SUB-UNIT

Publications (2)

Publication Number Publication Date
RU99114859A true RU99114859A (en) 2002-03-20
RU2215006C2 RU2215006C2 (en) 2003-10-27

Family

ID=25479526

Family Applications (2)

Application Number Title Priority Date Filing Date
RU99114859/13A RU2215006C2 (en) 1997-10-03 1998-10-02 METHOD FOR IDENTIFICATION OF BINDING MODULATING AGENT BETWEEN POLYPEPTIDE-αd AND VCAM-1 (VARIANTS)
RU2003121295/13A RU2003121295A (en) 1997-10-03 2003-07-14 NEW HUMAN BETA2-INTEGRINE SUB-UNIT

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2003121295/13A RU2003121295A (en) 1997-10-03 2003-07-14 NEW HUMAN BETA2-INTEGRINE SUB-UNIT

Country Status (12)

Country Link
US (1) US5837478A (en)
EP (1) EP0970124A2 (en)
JP (1) JP2001512989A (en)
CN (1) CN1144817C (en)
AU (1) AU740106B2 (en)
BR (1) BR9806323A (en)
CA (1) CA2273193A1 (en)
IL (3) IL130229A0 (en)
MX (1) MXPA04001057A (en)
NO (1) NO992667L (en)
RU (2) RU2215006C2 (en)
WO (1) WO1999020654A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620915B2 (en) * 1993-12-23 2003-09-16 Icos Corporation Monoclonal antibodies specific for integrin α-d subunit
US6770446B1 (en) * 1994-06-14 2004-08-03 Wyeth Cell systems having specific interaction of peptide binding pairs
US6489454B1 (en) * 1998-01-23 2002-12-03 Devgen Nv Engulfment gene and uses thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP2182008A3 (en) * 1998-11-16 2010-07-14 ICOS Corporation Monoclonal anti alpha-D (ITGAD) antibodies for use in the treatment of inflammation
US6867203B2 (en) 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US7166475B2 (en) * 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
JP2004527204A (en) * 2000-04-24 2004-09-09 ワイエス Novel cell lines with specific interaction of peptide binding pairs
DE60117743T2 (en) * 2001-11-05 2006-10-12 Warner-Lambert Co. Llc Screening method for modulators of integrins
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080194489A1 (en) * 2001-12-21 2008-08-14 Khan Nisar A Treatment of iatrogenic disease
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
JP4846799B2 (en) * 2005-07-05 2011-12-28 バイオテンプト ベー.フェー. Tumor treatment
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US20080217002A1 (en) * 2007-03-07 2008-09-11 Floyd Randolph Simonds Sand control screen having a micro-perforated filtration layer
CN101638429B (en) * 2009-08-28 2012-01-25 南方医科大学 Small molecular peptide of specificity recognition cell surface integrin alphal3beta1
EP2717293A1 (en) 2012-10-05 2014-04-09 Quercus Light GmbH Infrared radiation source and method for producing an infrared radiation source

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271139A (en) * 1978-03-27 1981-06-02 Hiram Hart Scintillation proximity assay
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
US5437958A (en) * 1993-12-23 1995-08-01 Icos Corporation Human β2 integrin α subunit
US5817515A (en) * 1993-12-23 1998-10-06 Icos Corporation Human B2 integrin alpha subunit antibodies
US5728533A (en) * 1993-12-23 1998-03-17 Icos Corporation Human β2 integrin αsubunit
US5470953A (en) * 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
CA2193828A1 (en) * 1994-06-29 1996-01-11 Timothy P. Kogan Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin

Similar Documents

Publication Publication Date Title
RU99114859A (en) NEW ALPHA SUB-UNIT BETA 2-HUMAN INTEGRINE
RU2215006C2 (en) METHOD FOR IDENTIFICATION OF BINDING MODULATING AGENT BETWEEN POLYPEPTIDE-αd AND VCAM-1 (VARIANTS)
CA1217121A (en) Enhanced luminescent or luminometric assay
EP0603953B1 (en) Use of 4' of 5'-hydroxy and 4'- or 5'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods
DE69232161D1 (en) Determination methods using induced luminescence
ATE204333T1 (en) METHOD FOR ATTENUATION OF FLUORESCENCE OF FLUORESCENCE-LABLED OLIGONUCLEOTIDES IN SOLUTION
EP0279097A3 (en) Immunoassay test strip
RU2004126254A (en) ACTRIIB KINASE ACTIVITY ANALYSIS
ATE414780T1 (en) METHODS FOR GENE TRANSFER USING RETROVIRUSES
FI96802B (en) A method for determining a viral antigen in a fluid and a kit for performing the method
CA2309879A1 (en) Nuclear hormone receptor drug screens
EP0354847A3 (en) Multiple fluorescence labelling with europium chelators
JP2005521411A5 (en)
ITRM910503A1 (en) METHOD FOR DETECTING MACROMOLECULES IMMOBILIZED ON A DIE
CA2358065A1 (en) Fluorescent intensity assay for protein or peptide binding to nucleic acids
WO2004044171A3 (en) Waveguide system for detection of fluorescently labeled nucleic acid sequences
ATE71460T1 (en) ASSAY DEVICE AND ITS APPLICATION.
ES8402939A1 (en) Specific binding assay method, reagent system and labelled conjugate for use in this method.
CY1106384T1 (en) PROTEIN-ACTIVATED RECEPTOR MODIFIER (PAR) ASSAYS
KR860003512A (en) Leukocyte detection composition
JP3179673B2 (en) Multilayer dry immunoassay element and method for performing immunoassay
EP0267521A3 (en) Method for the detection of nucleic acid hybrids
ES2178203T3 (en) METHODS AND REAGENTS TO MODULATE APOPTOSIS.
DE69331443D1 (en) METHOD FOR DETERMINING NUCLEIC ACIDS
WO1999061655A1 (en) Transition state binding assay